Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Treprostinil sodium

EU orphan designation number: EU/3/13/1103   
Active ingredient: Treprostinil sodium
Indication: Treatment of chronic thromboembolic pulmonary hypertension
Sponsor: SciPharm S.a.r.L
7, Fausermillen, 6689 Mertert, Luxembourg Grand Duchy of Luxembourg

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/02/2013 Orphan designation EMA/OD/154/12 (2013)804 of 8/02/2013
27/04/2016 Change of name and/or address of sponsor
22/05/2018 Change of name and/or address of sponsor